REGENERON PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
  • Regeneron Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $16.1M, a 10.6% decline year-over-year.
  • Regeneron Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $71.1M, a 11.4% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Interest Expense for 2023 was $73M, a 22.9% increase from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Interest Expense for 2022 was $59.4M, a 3.67% increase from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Interest Expense for 2021 was $57.3M, a 0.7% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $71.1M $16.1M -$1.9M -10.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $73M $18.3M +$900K +5.17% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-05
Q3 2023 $72.1M $17.8M +$2.5M +16.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $69.6M $18.9M +$5.8M +44.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $63.8M $18M +$4.4M +32.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $59.4M $17.4M +$3.3M +23.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-05
Q3 2022 $56.1M $15.3M +$1.1M +7.75% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $55M $13.1M -$1.3M -9.03% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $56.3M $13.6M -$1M -6.85% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $57.3M $14.1M -$700K -4.73% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-05
Q3 2021 $58M $14.2M -$12.1M -46% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $70.1M $14.4M +$4.7M +48.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $65.4M $14.6M +$8.5M +139% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $56.9M $14.8M +$8.1M +121% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-06
Q3 2020 $48.8M $26.3M +$18.5M +237% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $30.3M $9.7M +$1.7M +21.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $28.6M $6.1M -$1.6M -20.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $30.2M $6.7M -$800K -10.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-07
Q3 2019 $31M $7.8M +$400K +5.41% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $30.6M $8M +$1.1M +15.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $29.5M $7.7M +$1.3M +20.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $28.2M $7.5M +$1.48M +24.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-08
Q3 2018 $26.7M $7.4M +$1.22M +19.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $25.5M $6.9M +$1.5M +27.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $24M $6.4M -$1.1M -14.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $25.1M $6.02M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-07
Q3 2017 $6.18M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $5.4M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $7.5M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2015 $14.2M $3.61M -$2.74M -43.2% Oct 1, 2015 Dec 31, 2015 10-K 2016-02-11
Q3 2015 $17M $1.72M -$7.52M -81.4% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $24.5M $2.75M -$7.43M -73% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $31.9M $6.17M -$5.44M -46.9% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $37.4M $6.35M -$5.31M -45.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-11
Q3 2014 $42.7M $9.23M -$2.5M -21.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $45.2M $10.2M -$1.19M -10.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $46.4M $11.6M -$62K -0.53% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $46.4M $11.7M +$166K +1.44% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-11
Q3 2013 $46.3M $11.7M +$323K +2.83% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $45.9M $11.4M +$129K +1.15% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $45.8M $11.7M +$515K +4.62% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $45.3M $11.5M +$2.04M +21.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-12
Q3 2012 $43.3M $11.4M +$7.35M +181% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $35.9M $11.2M +$7.19M +178% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $28.7M $11.2M +$7.44M +200% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $21.3M $9.46M +$7M +285% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-13
Q3 2011 $14.3M $4.06M +$1.83M +81.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 $12.5M $4.05M +$1.71M +72.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 $10.8M $3.72M +$1.64M +78.5% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $9.12M $2.46M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $2.23M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $2.34M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $2.08M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.